1-2 of 2
Michael Schickler
Close
Save search
Sort by
Journal Articles

Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation

Free
Jacalyn Rosenblatt, MD, Irit Avivi, MD, Baldev Vasir, PhD, Lynne Uhl, MD, Tami Katz, PhD, Poorvi Somaiya, Heidi Mills, Robin Joyce, MD, James D. Levine, MD, Dimitrios Tzachanis, MD, PhD, Vassiliki A. Boussiotis, MD, PhD, Katarina Luptakova, MD, Jon E. Arnason, MD, Natalie Drummy, RN, Carol Delaney, RN, Emma Breault, Vicki Held, Lina Bisharat, Nancy Giallombardo, NP, Katharine Conway, NP, Jamie Mortellite, NP, Judith Wagoner, NP, Michael Schickler, PhD, Rinat Rotem-Yehudar, PhD, Paul G. Richardson, MD, Jacob P. Laubach, MD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD, Jacob M Rowe, MD, Donald Kufe, MD, David Avigan, MD
Journal: Blood
Blood (2012) 120 (21): 578.
https://doi.org/10.1182/blood.V120.21.578.578
Published: 2012
Journal Articles

CT-011, Anti-PD-1 Antibody, Enhances Ex-Vivo T Cell Responses to Autologous Dendritic/Myeloma Fusion Vaccine Developed for the Treatment of Multiple Myeloma.

Free
Jacalyn Rosenblatt, M.D., Brett Glotzbecker, MD, Heidi Mills, Whitney Keefe, Kerry Wellenstein, Baldev Vasir, PhD, Zekui Wu, MD, Corrine Zarwan, MD, Michael Schickler, PhD, Rinat Rotem-Yehudar, PhD, Donald Kufe, MD, David Avigan, MD
Journal: Blood
Blood (2009) 114 (22): 781.
https://doi.org/10.1182/blood.V114.22.781.781
Published: 2009